Chatham House, February 9-10


MipTec is the largest drug discovery conference in Europe with over 3,000 delegates from pharmaceutical companies


Stem Sells, Translational Medicine, Protein Therapeutics, Medicinal Chemistry and others


New in silico approaches to evaluating the efficacy of and repurposing drugs for aging and age-related diseases


The forum will attract many young scientists in aging research providing the possibility to recruit scarse talent with unique skills and interests


Unlike other aging conferences, the forum is geared towards the pharmaceutical industry addressing the need for new markers and new drugs within the traditional regulatory frameworks

Monday, May 4, 2015

Insilico Medicine SuperPharman Challenge: Looking for Superheros to Fight Aging

Super Heroes Needed at Insilico Medicine to Fight Cancer and Age-related Diseases

Aging fighters at Insilico Medicine are looking for relentless doers who dream big, but are not afraid to get their hands dirty with basic tasks. Doers, who have trouble sleeping at night, because they know that millions of people are suffering and dying of cancer and age-related diseases and their own clock is ticking as well. Doers with both programming and database management skills and knowledge of biology. You will need to know or quickly learn how to use huge multi-omics data to find alternative uses of currently available drugs and distribute many micro tasks to the crowd, freelancers or colleagues, while keeping the big picture in mind. 

We know that we are looking for a needle in the haystack, but this is how our team has come to be and you will be in great company. We have relentless super heroes in the US, UK, Switzerland, Poland, Israel, Russia and China. If you know someone amazing, who fits that profile amazing, ask him. Maybe he or she is already working for us. He goes through the day doing a boring academic job, but at night he is hacking away.

Our first frontier is transforming the pharmaceutical industry, repurposing known drugs and finding the new ones. When we launch, the world will become a better place. And if you are that super hero with bold ideas and hands on experience, ready to unleash maniacal energy to hack aging, send us a signal and we will respond right away or start watching you to see if you fit.

Here is a link to what Insilico Medicine is doing: 

In partnerships they can also do in vitro and in vivo validation, humouse clinical trials and even organ-on-a-chip and body-on-a-chip validation. 
They are looking for someone with similar skill set and energy as Alex Zhavoronkov ( to work together with him, gradually replace him and then find someone to replace yourself as the company grows or you decide to start a subsidiary. 

Minimum requirements:
  • Python, MySQL, Hadoop, AWS Services, IBM Watson
  • Experience working with multi-omics data and/or clinical trials/biomedical text data
  • SVM and deep learning algorithms
  • Basic knowledge of signaling and metabolic pathways
  • Experience working with GEO, ArrayExpress, KEGG, TCGA, LINCS, Connectivity Map, Drugbank, Clinical Trials, WHO databases, etc.
  • Personal network of contacts in academia and large pharmaceutical companies
  • Excellent writing skills
  • Ability to give public talks and generate publicity is a plus
  • Knowledge of Russian, Chinese or Hebrew is a plus

Sunday, January 4, 2015

Featured Conference: Chatham House


Ageing and Health – Policy and economics in an era of longevity

9th–10th February, 2015

A two-day international conference at ChathamHouse, London

Register Now
How can societies meet the health, policy and economic challenges of global population ageing?

One in nine people in the world is 60 or older and this is expected to rise to one in five people by 2050. A globally ageing population and the associated demographic changes have wide-ranging implications for health systems, medical priorities, economic policies, and labour and consumer markets.

The certainty of global population ageing demands greater action, innovation, and a long-term approach from policymakers, health and medical professionals as well as businesses. This conference will address critical questions, including:
  • Are current health, public policy and economic responses to global ageing adequate?
  • How can health systems develop sustainable strategies to support an ageing global population?
  • How can the challenge of managing chronic conditions be met and at what cost?
  • How can societies address the financial impact of ageing populations?
  • Are businesses reacting quickly enough to an ageing workforce and consumer base?
Speakers include:
  • László Andor, Commissioner for Employment, Social Affairs and Inclusion (2010-14), European Commission
  • Xiao Caiwei, Vice President, China National Committee on Ageing
  • Professor Kevin Fenton, Director of Health and Wellbeing, Public Health England
  • Dr Josep Figueras, Director, European Observatory on Health Systems and Policies
  • Dr Richard Jackson, President, Global Aging Institute
  • Dr Michael W Hodin, Executive Director, Global Coalition on Aging
  • Professor Tom Kirkwood, Dean for Ageing, Newcastle University Institute for Ageing
  • Dr Kiyoshi Kurokawa, Professor of the National Graduate Institute for Policy Studies; Chair, Health and Global Policy Institute, Japan
  • Dr Husseini Manji, Global Therapeutic Head for Neuroscience, Janssen Research & Development
  • Sarbjit Nahal, Head of Thematic Investing Strategy, Bank of America Merrill Lynch
  • Alana Officer, Senior Health Adviser, Ageing and Life Course, World Health Organization
  • Daniel Ryan, Head, Life and Health Research and Development, Swiss Re
  • Simon Stevens, Chief Executive, NHS England
  • Jannette Spiering, Director, De Hogeweyk Dementia Village
  • Nicoline Vackerberg, Coordinator, The Esther Network
For the full agenda, the speaker line up and to register please visit the event website.
Copyright © 2014 Biogerontology Research Foundation, All rights reserved.
We're reaching out to you as a relevant contact we hope is interested in our work.

Our mailing address is:
Biogerontology Research Foundation
Apt 2354
Chynoweth House, Trevissome Park
Truro, TR4 8UN
United Kingdom